irinotecan hydrochloride liposome injection
CSPC-DEY-BTC-01
Unknown small_molecule active
Quick answer
irinotecan hydrochloride liposome injection for Biliary Tract Carcinoma is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Biliary Tract Carcinoma
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active